Wednesday , May 25 2022
News
Industry News
Biosimilars
Business News
Cannabis Based Medicine
FDA News
Medical News
Precision Medicine
Press Releases
Specialty Pharmacy
Technology & Devices
Clinical News
Autoimmune Disorders
Crohn’s Disease
Endocrinology
Hematopoietics
Hemophilia
Hepatitis C
Hereditary Angioedema
HIV/AIDS
Hormonal Therapies
Clinical News
Immune Deficiencies
Infectious Diseases
Infertility
Lysosomal Storage Disorders
Macular Degeneration
Multiple Sclerosis
Nephrology
Oncology
Osteoarthritis
Clinical News
Osteoporosis
Psoriasis
Pulmonary Diseases
Rare Diseases
Renal Diseases
Rheumatoid Arthritis
Transplantation
Ulcerative Colitis
Von Willebrand Disease
Special Editions
Our Blog
Education
Media Inquiry
Archive
2014
2013
2012
2011
2010
Contact
Subscribe
Specialty Pharma Jobs
Post a Job
Search Jobs
Specialty Pharma Journal Specialty, Precision & Technology
News
Industry News
Biosimilars
Business News
Cannabis Based Medicine
FDA News
Medical News
Precision Medicine
Press Releases
Specialty Pharmacy
Technology & Devices
Clinical News
Autoimmune Disorders
Crohn’s Disease
Endocrinology
Hematopoietics
Hemophilia
Hepatitis C
Hereditary Angioedema
HIV/AIDS
Hormonal Therapies
Clinical News
Immune Deficiencies
Infectious Diseases
Infertility
Lysosomal Storage Disorders
Macular Degeneration
Multiple Sclerosis
Nephrology
Oncology
Osteoarthritis
Clinical News
Osteoporosis
Psoriasis
Pulmonary Diseases
Rare Diseases
Renal Diseases
Rheumatoid Arthritis
Transplantation
Ulcerative Colitis
Von Willebrand Disease
Special Editions
Our Blog
Education
Media Inquiry
Archive
2014
2013
2012
2011
2010
Contact
Subscribe
Specialty Pharma Jobs
Post a Job
Search Jobs
Breaking News
FDA Approves Gavreto for the Treatment of Adults with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
Incyte Announces Pivotal GEOMETRY mono-1 Study Results of Capmatinib in Patients with METex14 Metastatic Non-Small Cell Lung Cancer Published in NEJM
Natera Announces SMART Study Data for Aneuploidy and 22q Unblinded
Aimmune Agrees to be Acquired by Nestlé Health Science for $2 Billion
Twist Bioscience Announces Potent SARS-CoV-2 Neutralizing Data from COVID-19 Therapeutic Antibody Program
Final Analysis of the Observational GioTag Study: Sequential Afatinib and Osimertinib in Patients with EGFR Mutation-Positive NSCLC
Santhera Exercises Option to Obtain Worldwide Rights to Vamorolone in Duchenne Muscular Dystrophy and All Other Indications
FDA Approves Onureg, a New Oral Therapy, as Continued Treatment for Adults in First Remission with Acute Myeloid Leukemia
FDA Accepts Vertex’s sNDA for Trikafta, Symdeko and Kalydeco for Additional CFTR Mutations
Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program
Home
/
Employer Panel
Employer Panel
[wpjb_employer_panel]
Share
Facebook
Twitter
LinkedIn